Most people do not recognize cancer warning signs
the ONA take:
According to a new study published in the journal PLOS ONE, most people ignore cancer "alarm" symptoms. Researchers at University College London in London, United Kingdom, asked 1,724 participants aged 50 years and over whether they had experienced and of 17 cancer "alarm" symptoms.
Some symptoms included in the questionnaire were changes in mole appearance, difficulty swallowing, persistent change in bowel habits, unexplained bleeding, unexplained cough, unexplained lumps, and unexplained weight loss. Participants were not informed as to which symptoms are warning signs of cancer.
They were asked what they the thought to be the cause of any symptoms they experienced, as well as how serious they deemed the symptoms to be and if they visited the doctor as a result.
Of all respondents of the questionnaire, 53% reported experiencing at least one cancer warning symptom in the last 3 months and only 2% considered the warning symptoms to be cancer-related. Persistent cough and persistent change in bowel habits were the most common cancer warning signs experienced; unexplained weight loss and difficulty swallowing were the least.
Results showed that 59% of participants who experienced cancer signs visited a doctor. The findings suggest that many people who experience cancer signs do not realize the seriousness of their symptoms.
Most people ignore cancer "alarm" symptoms.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|